Prevest Denpro Share Price
Start SIP in Prevest Denpro
Start SIPPrevest Denpro Performance
Day Range
- Low 0
- High 0
52 Week Range
- Low 0
- High 0
- Open Price0
- Previous Close0
- Volume
Prevest Denpro Investment Rating
-
Master Rating:
-
Prevest Denpro has an operating revenue of Rs. 56.39 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 38% is great, ROE of 18% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 33% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 23 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 101 indicates it belongs to a poor industry group of Medical-Supplies and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 13 | 16 | 14 | 13 | 13 | 14 |
| Operating Expenses Qtr Cr | 9 | 10 | 9 | 9 | 8 | 8 |
| Operating Profit Qtr Cr | 4 | 6 | 4 | 5 | 5 | 6 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 1 | 2 | 1 | 1 | 1 | 1 |
| Net Profit Qtr Cr | 4 | 5 | 4 | 4 | 4 | 5 |
Prevest Denpro Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹591.45
- 50 Day
- ₹574.88
- 100 Day
- ₹532.71
- 200 Day
- ₹488.79
- 20 Day
- ₹580.48
- 50 Day
- ₹603.15
- 100 Day
- ₹509.38
- 200 Day
- ₹457.81
Prevest Denpro Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 623.70 |
| Second Resistance | 652.35 |
| Third Resistance | 666.70 |
| RSI | 51.15 |
| MFI | 79.91 |
| MACD Single Line | -0.94 |
| MACD | 0.32 |
| Support | |
|---|---|
| First Support | 580.70 |
| Second Support | 566.35 |
| Third Supoort | 537.70 |
Prevest Denpro Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 4,400 | 440,000 | 100 |
| Week | 10,000 | 1,000,000 | 100 |
| 1 Month | 17,562 | 1,756,190 | 100 |
| 6 Month | 21,636 | 1,823,679 | 84.29 |
Prevest Denpro Result Highlights
Prevest Denpro Synopsis
BSE-Medical-Supplies
Prevest Denpro belongs to the Industry of Medical Equipment & Accessories. Company’s Total Operating Revenue is Rs. 56.44 Cr. and Equity Capital is Rs. 12.00 Cr. for the Year ended 31/03/2024. Prevest Denpro Ltd. is a Public Limited Listed company incorporated on 05/05/1999 and has its registered office in the State of Jammu & Kashmir, India. Company’s Corporate Identification Number(CIN) is L85199JK1999PLC001969 and registration number is 001969.| Market Cap | 714 |
| Sales | 56 |
| Shares in Float | 0.31 |
| No of funds | 4 |
| Yield | 0.17 |
| Book Value | 8.06 |
| U/D Vol ratio | 1.7 |
| LTDebt / Equity | |
| Alpha | -0.01 |
| Beta | 1.14 |
Prevest Denpro Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 73.6% | 73.6% | 73.6% | 73.6% |
| Foreign Portfolio Investors | 1.11% | 0.52% | 0.31% | 0.31% |
| Individual Investors | 18.62% | 19.44% | 19.79% | 20.95% |
| Others | 6.67% | 6.44% | 6.3% | 5.14% |
Prevest Denpro Management
| Name | Designation |
|---|---|
| Mr. Atul Modi | Chairman & Managing Director |
| Mrs. Namrata Modi | WholeTime Director & CFO |
| Dr. Sai Kalyan Surapaneni | Executive Director |
| Mr. Vaibhav Munjal | Executive Director |
| Ms. Niharika Modi | Non Executive Director |
| Dr. Nikhil Shrikant Bobade | Independent Director |
| Dr. Sudeep Murthy | Independent Director |
| Mr. Pardeep Gandotra | Independent Director |
Prevest Denpro Forecast
Price Estimates
Prevest Denpro Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-08 | Quarterly Results & Final Dividend | |
| 2024-05-28 | Audited Results | (Revised) per share(10%)Final Dividend |
| 2024-02-03 | Quarterly Results | |
| 2023-11-03 | Half Yearly Results | |
| 2023-08-03 | Quarterly Results, Final Dividend & A.G.M. |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-30 | FINAL | Rs.1.00 per share(10%)Final Dividend |
| 2023-08-23 | FINAL | Rs.1.00 per share(10%)Final Dividend |
Prevest Denpro FAQs
What is Share Price of Prevest Denpro ?
Prevest Denpro share price is ₹595 As on 08 September, 2024 | 02:09
What is the Market Cap of Prevest Denpro ?
The Market Cap of Prevest Denpro is ₹714.2 Cr As on 08 September, 2024 | 02:09
What is the P/E ratio of Prevest Denpro ?
The P/E ratio of Prevest Denpro is 45.4 As on 08 September, 2024 | 02:09
What is the PB ratio of Prevest Denpro ?
The PB ratio of Prevest Denpro is 8.1 As on 08 September, 2024 | 02:09